MX2025014366A - Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos - Google Patents

Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos

Info

Publication number
MX2025014366A
MX2025014366A MX2025014366A MX2025014366A MX2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A MX 2025014366 A MX2025014366 A MX 2025014366A
Authority
MX
Mexico
Prior art keywords
psychiatric
disorders
treatment
psychoactive drugs
neurological diseases
Prior art date
Application number
MX2025014366A
Other languages
English (en)
Spanish (es)
Inventor
Blake Mandell
Martin Stogniew
Jennifer Louise Schmidt
Markus Seelig
Original Assignee
Transcend Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transcend Therapeutics Inc filed Critical Transcend Therapeutics Inc
Priority claimed from PCT/US2024/032615 external-priority patent/WO2024254190A2/en
Publication of MX2025014366A publication Critical patent/MX2025014366A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
MX2025014366A 2023-06-06 2024-06-05 Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos MX2025014366A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202363471412P 2023-06-06 2023-06-06
US202363602904P 2023-11-27 2023-11-27
US202363605729P 2023-12-04 2023-12-04
US202363607702P 2023-12-08 2023-12-08
US202463553788P 2024-02-15 2024-02-15
US202463649653P 2024-05-20 2024-05-20
PCT/US2024/032615 WO2024254190A2 (en) 2023-06-06 2024-06-05 Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders

Publications (1)

Publication Number Publication Date
MX2025014366A true MX2025014366A (es) 2026-02-03

Family

ID=98099691

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2025014366A MX2025014366A (es) 2023-06-06 2024-06-05 Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos

Country Status (5)

Country Link
EP (1) EP4724433A2 (de)
KR (1) KR20260053276A (de)
AU (1) AU2024284688A1 (de)
IL (1) IL324918A (de)
MX (1) MX2025014366A (de)

Also Published As

Publication number Publication date
EP4724433A2 (de) 2026-04-15
AU2024284688A1 (en) 2025-12-11
IL324918A (en) 2026-01-01
KR20260053276A (ko) 2026-04-21

Similar Documents

Publication Publication Date Title
MX2026002446A (es) Compuestos macrociclicos, metodo de preparacion de estos y uso de estos
ECSP21004787A (es) Inhibidores de inflamasoma nlrp3
AR127050A1 (es) Compuestos espirocíclicos
ECSP034602A (es) Derivados sustituidos 2-fenilaminoimidazolina fenil cetona como antagonistas ip
AR123685A1 (es) Antagonistas del mrgx2
MX2024009161A (es) Compuestos de pirrolidina.
CY1124708T1 (el) Φαρμακολογικως δραστικα αλικυκλικα υποκατεστημενα παραγωγα πυραζολο[1,5-a] πυριμιδινης
CL2020001020A1 (es) Derivados de bencimidazol y sus usos.
CO2022006087A2 (es) Métodos para el tratamiento de la trombocitopenia inmunitaria mediante la administración de (r)-2-[3-[4-amino-3-(2-fluoro-4-fenoxi-fenil)pirazolo[3,4-d]pirimidin-1-il]piperidino-1-carbonil]-4-metil-4-[4-(oxetan-3-il)piperazin-1-il]pent-2-enonitrilo
CR20240536A (es) Compuestos amido heteroaromáticos útiles en el tratamiento de enfermedades hepáticas
CO2025015728A2 (es) Conjugados que comprenden enlazadores escindibles
CO2023001367A2 (es) Derivados de pirazolo[1,5-a]pirimidina sustituidos con heterocíclicos farmacológicamente activos
AR131735A1 (es) Agentes terapéuticos
MX2025013370A (es) Inhibidores de moléculas pequeñas de glutaminasa
MX2024012095A (es) Medicamentos psicoactivos y su uso para el tratamiento de enfermedades y trastornos psiquiátricos y neurológicos
MX2021008213A (es) Derivados de (2,5-dioxopirrolidina-1-il)(fenil)-acetamida y su uso en el tratamiento de enfermedades neurologicas.
CO2026003028A2 (es) Conjugados que comprenden enlazadores escindibles
ECSP19084722A (es) Compuestos bicíclicos 5,6-fusionados y composiciones para el tratamiento de enfermedades parasitarias
AR035008A1 (es) Compuestos pirimidin-2, 4, 6-trionas, su uso para la fabricacion de un medicamento y composicion farmaceutica que los comprende
CO2024014215A2 (es) Formulaciones de inhibidor de tyk2 y métodos para elaborarlas
AR038046A1 (es) Derivados de acidos 3-fenil-2-arilalquiltiopropionicos moduladores de ppar alfa
WO2024254190A3 (en) Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
CL2024003257A1 (es) Compuestos heteroaromáticos bicíclicos condensados y su uso en el tratamiento del cáncer
AR127170A1 (es) Antagonistas del receptor de la hormona paratiroidea (pth) y sus usos
MX2024009770A (es) Procesos para la preparacion de derivados de 1,2,3,5,6,7-hexahidro -s-indaceno.